Radioactive iodine remnant ablation (RRA) is used to destroy residual normal thyroid tissue
after complete gross surgical resection of papillary or follicular thyroid cancer. The article …

Thyroid cancer is one of the fastest growing diagnoses; more cases of thyroid cancer are
found every year than all leukemias and cancers of the liver, pancreas, and stomach. Most of …

Context: Although response to therapy assessment is a validated tool for dynamic risk
stratification in patients with differentiated thyroid cancer (DTC) treated with total …

Background Although recurrence and death can occur in patients with papillary thyroid
cancer (PTC) several years after being diagnosed, the necessary duration of follow-up for …

Context Substantial uncertainty persists about the indications for radioactive iodine for
thyroid cancer. Use of radioactive iodine over time and the correlates of its use remain …

Background Contemporary guidelines for managing PTC advise an approach wherein
primary tumor and regional metastases (RM) are completely resected at first surgery and …

Background: Follicular variant of papillary thyroid carcinoma (FV-PTC) has been
increasingly diagnosed in recent years. However, little is known about its clinical behavior …

Staging and risk stratification predicate the postoperative management of thyroid cancer
patients, determining not only the need for 131I therapy or alternative options (conservative …

Целью этой книги является предоставление практическому врачу накопленной в мире
информации об эпидемиологии, этиологии, патогенезе, прикладной анатомии …

Objective: To determine the risk of second primary malignancies (SPMs) in thyroid cancer
survivors. Design: We performed a systematic review and meta-analysis examining the …